Display options
Share it on

Inflammation. 1983 Mar;7(1):35-47. doi: 10.1007/BF00918006.

Modulation of human mononuclear cell responses by neutrophil-derived factors. II. Partial characterization of a neutrophil-derived lymphocyte-enhancing factor (N-LEF).

Inflammation

R S Panush

PMID: 6601617 DOI: 10.1007/BF00918006

Abstract

We previously reported that neutrophil (PMN)-derived factors modulated human mononuclear cell (MNC) responses. These interactions are important in understanding MNC localization, growth, and activation in inflammatory events such as occur in the rheumatoid synovium. We have partially identified and characterized a human neutrophil-derived, lymphocyte-enhancing factor (N-LEF). Highly purified PMN, devoid of MNC or platelets, were obtained by density gradient sedimentation. Supernatants (spt) were prepared from PMN phagocytosis of complement-coated zymosan particles. N-LEF was determined by [3H]TdR uptake or Ig secretion by stimulated MNC of cell lines. Neutral protease activity was quantitated by digestion of 125I-labeled Hb. Sodium dodecylsulfate (SDS) polyacrylamide gel electropheresis (PAGE) was carried out in 15% gels. We found (1) N-LEF biologic activity was cold stable, heat labile, nondialyzable, and diminished at acid pH (less than 4) or alkaline pH (greater than 10); (2) N-LEF biologic activity was abrogated by human plasma; (3) spt contained neutral protease and granule-associated but not cytoplasmic enzyme activities; (4) protease activities (for Hb, fibrin, ATEE, and Ac-Phe-BNa) were recovered from aprotinin-sepharose affinity columns and contained approximately 25,000 and approximately 28,000 molecular weight material on SDS-PAGE; (5) absorbtion of N-LEF spt on aprotinin-sepharose diminished both protease and biologic activities; and (6) N-LEF biologic activity and nonelastase neutral protease activity were found in approximately 13,000 mol wt fractions of Sephadex G100 (where cathepsin G chromatographs). Our observations suggest that phagocytosis of immune complexes by PMN induces release of a mononuclear cell enhancing factor, N-LEF, which may be an important mediator of inflammation, promoting transition from an acute to a chronic inflammatory response. Biologic properties of N-LEF are those of cathepsin G.

References

  1. Rheumatology. 1975;6:156-66 - PubMed
  2. Clin Chim Acta. 1967 Mar;15(3):435-47 - PubMed
  3. N Engl J Med. 1981 Feb 26;304(9):518-20 - PubMed
  4. Experientia. 1973 Apr 15;29(4):481-3 - PubMed
  5. Biochim Biophys Acta. 1975 Feb 27;379(2):606-17 - PubMed
  6. Ann N Y Acad Sci. 1964 Dec 28;121:404-27 - PubMed
  7. J Immunol. 1981 Mar;126(3):834-7 - PubMed
  8. Adv Immunol. 1973;16(0):265-336 - PubMed
  9. J Immunol. 1975 Aug;115(2):533-8 - PubMed
  10. J Immunol. 1976 Jul;117(1):1-6 - PubMed
  11. J Clin Lab Immunol. 1980 Sep;4(2):107-10 - PubMed
  12. Cell Immunol. 1976 Jan;21(1):161-76 - PubMed
  13. Clin Exp Immunol. 1977 Feb;27(2):254-60 - PubMed
  14. J Clin Lab Immunol. 1982 Oct;9(1):39-47 - PubMed
  15. Ann N Y Acad Sci. 1964 Dec 28;121:321-49 - PubMed
  16. Biochim Biophys Acta. 1975 Oct 22;403(2):477-92 - PubMed
  17. N Engl J Med. 1975 Sep 11;293(11):517-20 - PubMed
  18. J Immunol. 1977 Dec;119(6):2019-23 - PubMed
  19. Fed Proc. 1971 Nov-Dec;30(6):1721-4 - PubMed
  20. Arthritis Rheum. 1969 Apr;12(2):103-16 - PubMed
  21. J Immunol. 1979 Jun;122(6):2633-5 - PubMed
  22. Arthritis Rheum. 1971 Nov-Dec;14(6):737-47 - PubMed
  23. J Clin Lab Immunol. 1981 Mar;5(2):113-20 - PubMed
  24. Inflammation. 1983 Mar;7(1):35-47 - PubMed
  25. Hoppe Seylers Z Physiol Chem. 1974 Sep;355(9):1077-82 - PubMed
  26. Int Arch Allergy Appl Immunol. 1966;29(2):185-9 - PubMed
  27. Am J Clin Pathol. 1958 Sep;30(3):234-6 - PubMed
  28. Arthritis Rheum. 1980 May;23(5):556-63 - PubMed
  29. J Exp Med. 1976 Oct 1;144(4):863-72 - PubMed
  30. J Biol Chem. 1979 Jun 25;254(12):5000-7 - PubMed
  31. Ann Rheum Dis. 1981 Aug;40(4):396-9 - PubMed
  32. J Immunol. 1980 Jan;124(1):94-9 - PubMed
  33. Cell Immunol. 1974 Jan;10(1):86-104 - PubMed
  34. Hoppe Seylers Z Physiol Chem. 1977 May;358(5):555-64 - PubMed
  35. J Exp Med. 1974 Apr 1;139(4):834-50 - PubMed
  36. J Rheumatol. 1977 Autumn;4(3):231-44 - PubMed
  37. Nature. 1974 May 10;249(453):144-5 - PubMed
  38. J Exp Med. 1975 Jul 1;142(1):151-64 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources